SE8400723L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8400723L
SE8400723L SE8400723A SE8400723A SE8400723L SE 8400723 L SE8400723 L SE 8400723L SE 8400723 A SE8400723 A SE 8400723A SE 8400723 A SE8400723 A SE 8400723A SE 8400723 L SE8400723 L SE 8400723L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
trimethylpropylguanidine
pinacidil
pyridyl
cyano
Prior art date
Application number
SE8400723A
Other languages
Unknown language ( )
English (en)
Other versions
SE8400723D0 (sv
SE447871B (sv
Inventor
E J Didriksen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SE8400723D0 publication Critical patent/SE8400723D0/sv
Publication of SE8400723L publication Critical patent/SE8400723L/sv
Publication of SE447871B publication Critical patent/SE447871B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8400723A 1983-02-11 1984-02-10 Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar SE447871B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat

Publications (3)

Publication Number Publication Date
SE8400723D0 SE8400723D0 (sv) 1984-02-10
SE8400723L true SE8400723L (sv) 1984-08-12
SE447871B SE447871B (sv) 1986-12-22

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400723A SE447871B (sv) 1983-02-11 1984-02-10 Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar

Country Status (15)

Country Link
US (1) US4600577A (sv)
JP (1) JPS59155312A (sv)
BE (1) BE898882A (sv)
DE (1) DE3404595A1 (sv)
DK (1) DK58983D0 (sv)
ES (1) ES8608490A1 (sv)
FR (1) FR2540727B1 (sv)
GB (1) GB2134785B (sv)
IE (1) IE56604B1 (sv)
IT (1) IT1196682B (sv)
NL (1) NL8400430A (sv)
NZ (1) NZ207010A (sv)
PH (1) PH21734A (sv)
SE (1) SE447871B (sv)
ZA (1) ZA84856B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
JP2002535353A (ja) 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US6417207B1 (en) * 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
JP5502254B2 (ja) * 2001-01-31 2014-05-28 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 少なくとも２種類の異なる被覆ペレット形から成る多粒子剤形
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
RU2010119041A (ru) 2007-10-12 2011-11-20 Такеда Фармасьютикалз Норт Америка, Инк. (Us) Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Also Published As

Publication number Publication date
IT8467131A0 (it) 1984-02-13
FR2540727A1 (fr) 1984-08-17
GB2134785A (en) 1984-08-22
ZA84856B (en) 1984-09-26
DE3404595C2 (sv) 1993-04-29
PH21734A (en) 1988-02-10
GB2134785B (en) 1986-07-02
BE898882A (fr) 1984-08-10
IE840146L (en) 1984-08-11
DE3404595A1 (de) 1984-08-16
FR2540727B1 (fr) 1987-01-23
IT1196682B (it) 1988-11-25
US4600577A (en) 1986-07-15
JPS59155312A (ja) 1984-09-04
IT8467131A1 (it) 1985-08-13
GB8403572D0 (en) 1984-03-14
ES8608490A1 (es) 1986-06-16
JPH0451528B2 (sv) 1992-08-19
NL8400430A (nl) 1984-09-03
SE8400723D0 (sv) 1984-02-10
IE56604B1 (en) 1991-10-09
NZ207010A (en) 1987-06-30
SE447871B (sv) 1986-12-22
DK58983D0 (da) 1983-02-11
ES529660A0 (es) 1986-06-16

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
IT8247801A0 (it) Articolo assorbente, in particolare assorbente igienico contenente mezzi per la gelificazione del sangue
JO1425B1 (en) New vehicles
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
SE8400723D0 (sv) Farmaceutisk komposition
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
DE3583799D1 (de) Feste zubereitung mit langsamer freisetzung.
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
FI885122A7 (sv) Oral komposition innehållande partiklar som omfattar ett aktivt ämne
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE2861089D1 (en) Dihydropyridazones, their preparation and medicines containing them and dihydropyridazones for use in medical treatments
IL71871A0 (en) Two-phase medicament formulation containing nifedipine and its preparation
AU563762B2 (en) S-adenosyl-l-methionine salts preparation
IL97607A0 (en) Retinoids,their manufacture and pharmaceutical compositions containing them
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
IT1079246B (it) Potrona d'intervento per gabinetti medici,dentisti e simili
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DK149545C (da) Stol omfattende saede, ryglaen og ben
NO874241D0 (no) Terapeutisk aktive salter.
FI842538A7 (sv) Bicyklo(3.2.1)oktankarboxylsyraderivat, förfarande för deras framställning samt deras terapeutiska användning.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
DK0402208T3 (da) Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8400723-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8400723-6

Format of ref document f/p: F